To study the effect of Pavanari Rasa for pain management in Amavata.
- Conditions
- Autoinflammatory syndromes. Ayurveda Condition: AMAVATAH,
- Registration Number
- CTRI/2023/07/055293
- Lead Sponsor
- National Institute of Ayurveda
- Brief Summary
Participants attending the OPD and IPD of the NIA hospital and satisfying the selection criteria will
be selected. All the participants who voluntarily agree to participate and provide informed written
consent for participation will be recruited in the study.
Total 40 participants will be selected after details examination and divided in 2 group of 20 patients
each as per study protocol. All Procedures will be executed under aseptic condition .
The changes observed in the sign and symptoms will be assessed by adopting suitable
scoring method and the objective signs by using appropriate clinical tools- Baseline and weekly .
DAS-28 score & ESR will be assessed on the Baseline and 15th day of the study .
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
- 1.Patients willing to sign consent form for the clinical trial.
- 2.Patients between the age group of 25 to 60 years, irrespective of sex and socio-economic status.
- 3.Patients having signs and symptoms of ‘Amavata’ (Rheumatoid Arthritis) 4.Patients fulfill the criteria of ACR / EULAR 2010 criteria (American College of Rheumatology /European League Against Rheumatism) 5.Patients with chronicity of less than 5 years.
- 1.Patients having severe joint deformities.
- 2.Patients having age < 20 years & > 60 years .
- 3.Patients suffering from paralysis.
- 4.Patients having any type of arthropathy such as Neoplasm of spine, Gout, Ankylosing spondylosis, Traumatic arthritis and Pyogenic osteomyelitis etc.
- 5.Patients having associated Cardiac disease, Tuberculosis, Diabetes mellitus, Malignant Hypertension, Renal Function Impairment, Hypothyroidism, Rheumatic Heart Disease etc.
- 6.Patients with extremely reduced joint space.
- 7.Pregnant women and lactating mother.
- 8.Patient taking disease modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in Pain score. 14 days
- Secondary Outcome Measures
Name Time Method Changes in symptoms of Amavata, Improvement in quality of life and changes in DAS-28 score, CRP, RA Factor, Disability Index Score, other symptoms, Improvement in walking time,hand &foot grip. 30 days
Trial Locations
- Locations (1)
Hospital, National Institute of Ayurveda Deemed to be University Jaipur
🇮🇳Jaipur, RAJASTHAN, India
Hospital, National Institute of Ayurveda Deemed to be University Jaipur🇮🇳Jaipur, RAJASTHAN, IndiaDrTapaswini DalasinghrayPrincipal investigator7008756788tapaswinidalasinghray@gmail.com